Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Strategies for managing today's infections
Y. Carmeli
*
*
Corresponding author for this work
Tel Aviv Sourasky Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
40
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Strategies for managing today's infections'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acinetobacter
33%
Acinetobacter Infections
33%
Antimicrobial
33%
Bacterial Infection
33%
Causative Pathogen
33%
Clinical Opinion
33%
Difficult-to-treat
33%
Empirical Therapy
66%
Enterobacteriaceae
33%
Enterococcus
33%
Enterococcus Spp
33%
Healthcare Settings
33%
Highly Active
33%
Infection Severity
33%
Infection Site
33%
Local Resistance
33%
Methicillin Resistance
33%
Methicillin-resistant S. Aureus
33%
Nosocomial Infection
33%
Opinion Leaders
33%
Prescribers
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Pseudomonas Infections
33%
Public Health Risk
33%
Resistance Pattern
100%
Risk Factors
33%
Serious Disease
33%
Staphylococcus Aureus
66%
Vancomycin Resistance
66%
Virulence
33%
Medicine and Dentistry
Acinetobacter
25%
Acinetobacter Infection
25%
Antiinfective Agent
25%
Antimicrobial Agent
25%
Bacterial Infection
25%
Diseases
25%
Enterobacteriaceae
25%
Enterococcus
50%
Hospital Infection
25%
Infection
100%
Methicillin Resistance
25%
Meticillin
25%
Pathogen
75%
Pseudomonas aeruginosa
25%
Public Health
25%
Staphylococcus Aureus
75%
Vancomycin Resistance
50%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
25%
Acinetobacter Infection
25%
Antiinfective Agent
25%
Antimicrobial Agent
25%
Bacterial Infection
25%
Diseases
25%
Enterobacteriaceae
25%
Enterococcus
50%
Hospital Infection
25%
Infection
100%
Infectious Agent
75%
Meticillin
50%
Pseudomonas aeruginosa
25%
Staphylococcus Aureus
75%
Vancomycin
50%
Biochemistry, Genetics and Molecular Biology
Acinetobacter
66%
Enterobacteriaceae
33%
Enterococcus
66%
Infectious Agent
100%
Methicillin Resistance
33%
Pseudomonas aeruginosa
33%
Staphylococcus Aureus
100%
Vancomycin Resistance
66%
Nursing and Health Professions
Acinetobacter Infection
25%
Antiinfective Agent
25%
Antimicrobial Agent
25%
Bacterial Infection
25%
Diseases
25%
Hospital Infection
25%
Infection
100%
Meticillin
50%
Nutrition Policy
25%
Vancomycin
50%